- In April 2025, DHL Supply Chain announced an expansion of its temperature-controlled logistics network in Southeast Asia to support the growing demand for clinical trial shipments in the region. This initiative aims to enhance the secure and timely delivery of temperature-sensitive investigational drugs
- In March 2024, Myonex, a leading global clinical trial supply company, announced an agreement to acquire Creapharm Group's clinical and commercial packaging and distribution business, as well as its bioservices. Creapharm is headquartered in Reims, France, with additional sites in France and Georgia, USA.
- In September 2022, Parexel, a leading global clinical research organization (CRO), announced the opening of a new clinical trial supplies and logistics depot in Suzhou, China. This strategically located facility will provide local and international biopharmaceutical companies conducting clinical trials in the region with timely access to necessary supplies and investigative treatments for distribution to clinical sites and patients worldwide.
